Madingley, Cambridgeshire, United Kingdom Avlar BioVentures is the famous VC, which was founded in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Madingley.
Considering the real fund results, this VC is 7 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2005. This Avlar BioVentures works on 22 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars.
The current fund was established by Alan G. Goodman. We also calculated 2 valuable employees in our database.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Avlar BioVentures, startups are often financed by Excalibur Fund Managers, UK Innovation & Science Seed Fund, Scottish Equity Partners. The meaningful sponsors for the fund in investment in the same round are Excalibur Fund Managers, UK Innovation & Science Seed Fund, Providence Investment Company Limited. In the next rounds fund is usually obtained by Excalibur Fund Managers, UK Innovation & Science Seed Fund, Scottish Equity Partners.
For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Crescendo Biologics, Purely Proteins Limited, Takeda Cambridge. Among the most popular fund investment industries, there are Health Care, Software. The fund has specific favorite in a number of founders of portfolio startups.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anzhuoxin Venture Capital | China, Guangdong Province, Huizhou |
| Apothecary Capital | Chicago, Illinois, United States |
| Bialla Venture Partners | Maryland, Severna Park, United States |
| Greenhouse Capital Partners | California, Sausalito, United States |
| Manitou Ventures | California, San Francisco, United States |
| MegaChips | Japan, Osaka, Osaka Prefecture |
| Raised In Space Enterprises | California, Santa Monica, United States |
| Rhiza Capital / Sunshine Coast Venture Partners | - |
| Zamagias Properties Inc. | Pennsylvania, Pittsburgh, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Crescendo Biologics | $7M | 20 Jan 2010 | England | ||
Crescendo Biologics | $6M | 12 Oct 2009 | England | ||
| $3M | 01 Dec 2004 | England | |||
CellCentric | 03 Jun 2004 | Cambridge, England, United Kingdom | |||
| 26 Nov 2003 | United Kingdom, England | ||||
De Novo Pharmaceuticals | $23M | 26 Jul 2001 | Cambridge, England, United Kingdom | ||
De Novo Pharmaceuticals | $2M | 18 Apr 2000 | United Kingdom, England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Crescendo Biologics | $7M | 20 Jan 2010 | England | ||
Crescendo Biologics | $6M | 12 Oct 2009 | England | ||
| $3M | 01 Dec 2004 | England | |||
CellCentric | 03 Jun 2004 | Cambridge, England, United Kingdom | |||
| 26 Nov 2003 | United Kingdom, England | ||||
De Novo Pharmaceuticals | $23M | 26 Jul 2001 | Cambridge, England, United Kingdom | ||
De Novo Pharmaceuticals | $2M | 18 Apr 2000 | United Kingdom, England |
